Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
about
Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dissociation between the pharm ...... a randomized crossover study.
@en
Dissociation between the pharm ...... a randomized crossover study.
@nl
type
label
Dissociation between the pharm ...... a randomized crossover study.
@en
Dissociation between the pharm ...... a randomized crossover study.
@nl
prefLabel
Dissociation between the pharm ...... a randomized crossover study.
@en
Dissociation between the pharm ...... a randomized crossover study.
@nl
P2093
P2860
P356
P1476
Dissociation between the pharm ...... a randomized crossover study.
@en
P2093
M Hemmrich
P B Persson
S Heitmeier
P2860
P304
P356
10.1111/JTH.13801
P577
2017-08-14T00:00:00Z